[\'University of Kentucky, Lexington, KY, USA.\', \'The University of Kansas Health System, Kansas City, KS, USA.\', \'ProMedica Toledo Hospital, Toledo, OH, USA.\']
Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure.